GlassScriptPhysician profile
Sina Moainie
NPI 1285759977
$183,550.72
in general payments reported to CMS, 2019-2025
14 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $19K · 2021: $18K · 2022: $21K · 2023: $18K · 2024: $20K · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,506 · Food and Beverage: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,037.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,506.25 |
| Food and Beverage | $1,745.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $77,551.39 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Medtronic Vascular, INC. | $69,338.14 | 2019-2020 | |
| Medtronic, INC. | $22,287.26 | 2021-2024 | Corevalve Evolut R |
| Cook Research Incorporated | $8,746.70 | 2019-2020 | |
| Livanova USA, INC. | $2,258.67 | 2019 | |
| Abbott Laboratories | $1,072.67 | 2019-2025 | Epic, Navitor |
| Boston Scientific Corporation | $914.49 | 2019 | |
| Edwards Lifesciences Corporation | $600.44 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Helios Cardio INC | $193.50 | 2025 | Cardiamend |
| Abiomed | $142.28 | 2023 | Impella |
| Angiodynamics, INC. | $142.27 | 2024 | Angiovac |
| Cook Medical LLC | $141.59 | 2025 | Zenith Spiral-Z |
| W. L. Gore & Associates, INC. | $112.27 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Covidien LP | $49.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sina Moainie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.